HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidine

has antineoplastic activity; structure in first source
Also Known As:
GDC 0941; GDC-0941; GDC0941
Networked: 62 relevant articles (12 outcomes, 15 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Friedman, Lori S: 10 articles (03/2014 - 09/2008)
2. Belvin, Marcia: 9 articles (03/2014 - 06/2009)
3. Salphati, Laurent: 6 articles (07/2014 - 09/2008)
4. Sampath, Deepak: 6 articles (03/2014 - 05/2009)
5. Wallin, Jeffrey J: 5 articles (03/2014 - 07/2010)
6. Berry, Leanne: 4 articles (01/2013 - 07/2010)
7. Prior, Wei Wei: 4 articles (07/2012 - 07/2010)
8. Fulda, Simone: 3 articles (02/2015 - 01/2012)
9. Pang, Jodie: 3 articles (07/2014 - 09/2008)
10. Edgar, Kyle A: 3 articles (03/2014 - 09/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Anoxia (Hypoxia)
4. Glioblastoma (Glioblastoma Multiforme)
5. Glioma (Gliomas)

Related Drugs and Biologics

1. docetaxel (Taxotere)
2. trastuzumab (Herceptin)
3. Ellagic Acid
4. DNA (Deoxyribonucleic Acid)
5. sorafenib (BAY 43-9006)
6. gefitinib (Iressa)
7. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
8. triciribine
9. Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
10. AZD 6244

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Lasers (Laser)
3. Aftercare (After-Treatment)